We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Vaccines

Vaccines

Featured Articles

Cell Culture Advances for Vaccine Development and Production

Cell Culture Advances for Vaccine Development and Production

This article will explore how the optimization of cell culture growth medium, the development of superior biological models and the reduced reliance on animal-derived components continue to drive the exciting and rapidly developing art of cell-based vaccine development.

The Placebo Response ‒ A Powerful Phenomenon

The Placebo Response ‒ A Powerful Phenomenon

In a recent interview, Technology Networks had the pleasure of speaking with Professor Ted J. Kaptchuk, leading figure in placebo studies and a scholar of East Asian medicine, about the importance of humanistic dimensions of care, what is currently known about the neurobiology and genetics of placebo effects, open-label placebo studies and ethical use of placebos in clinical practice.

Transmissible and Transferable Vaccines

Transmissible and Transferable Vaccines

What are transmissible and transferable vaccines? How can they be utilized to protect against zoonotic viruses? In this article, Demetria Dickinson explores key concepts and research advances in transmissible and transferable vaccines.

Latest Articles

Progress Towards a Mucosal Vaccine for Pneumonia

Progress Towards a Mucosal Vaccine for Pneumonia

In a new study, researchers describe a subunit mucosal vaccine that induces broadly protective immunity against Klebsiella pneumoniae strains. Technology Networks interviewed author Jay Kolls to learn more about the findings and their significance.

Nanoparticles – Enabling Innovation in Vaccine Design

Nanoparticles – Enabling Innovation in Vaccine Design

Nanoparticle-based vaccines have emerged as a potential alternative to conventional and subunit vaccines. This article explores the various properties and advantages of nanoparticles which allow the design of vaccines with enhanced antigen presentation and strong immunogenicity.

The Biotech Boom: Making Light Work of Market Access

The Biotech Boom: Making Light Work of Market Access

This article outlines a five-step plan to help biotechs and biological pharma companies cut through the market complexities to get their new products to market swiftly and cost-efficiently.

Liquid Chromatography in the Biopharmaceutical Industry

Liquid Chromatography in the Biopharmaceutical Industry

Biopharmaceuticals have become invaluable tools for the treatment of a variety of diseases. Learn about the role liquid chromatography is playing in ensuring their efficacy, safety and stability, and the challenges these molecules pose for analysts.

A Note to the Vaccinated: Thank You and Be Reassured

A Note to the Vaccinated: Thank You and Be Reassured

Recent headlines sparked fear after discussing waning immunity to SARS-CoV-2 after vaccination. In this op-ed, immunologist Michael Kinch addresses the subject of the articles and explains why it is normal for antibody levels in the blood to wane over time.

Leveraging the Power of Genomics To Detect and Track SARS-CoV-2 Variants

Leveraging the Power of Genomics To Detect and Track SARS-CoV-2 Variants

Monitoring changes in the viral genome is continuing to play a crucial role in shaping the response to the COVID-19 pandemic.

COVID-19 Vaccine Stockpiling and Its Potential Impact

COVID-19 Vaccine Stockpiling and Its Potential Impact

This article explores the concept of vaccine stockpiling, and how genomic surveillance and mathematical modeling can help us to understand its potential impact on the SARS-CoV-2 virus and the pandemic response.

Teach Me in 10 Hub Page

Teach Me in 10 Hub Page

At Technology Networks we understand the importance of time. That's why we've launched Teach Me in 10 a video series that challenges scientists to present and summarize their research area, a scientific concept, or technology in 10 minutes or less.

Troublesome Threesome for Vaccine Development

Troublesome Threesome for Vaccine Development

The need for new vaccines for HIV, Tuberculosis (TB) and malaria are all the greater after the pandemic, but will vaccine advances for SARS-CoV-2 help? Anthony King explores for Technology Networks.

Making Vaccines Accessible to All: A Conversation With UNICEF

Making Vaccines Accessible to All: A Conversation With UNICEF

Technology Networks spoke with UNICEF about the challenges in achieving vaccine equality, what factors contribute to low immunization rates, how we can work to make vaccines available to marginalized communities and the consequences of vaccine inequality.

Advertisement

Advertisement